Kidney Injury
Conditions
Brief summary
To study the difference in mortality and major adverse kidney events during and after treatment in the emergency department with intravenous fluids per standard of care at 30 days before and after the system-wide implementation.
Interventions
OTHERData Inclusion
Patients in this group will be included in the project
Sponsors
Intermountain Health Care, Inc.
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Adult patients (≥18 years) receiving a minimum of 1000ml of intravenous fluids starting in the emergency department per standard of care
Exclusion criteria
* Patients aged ≤17 years * Previously enrolled patients with \>1 ED admission within the 30-day follow-up period
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of participants with major Adverse Kidney Events | within 30 days or at hospital discharge | death from any cause, new renal replacement therapy or persistent renal dysfunction |
| LR IV Fluids administered | Through study completion (an average of 1 year) | Proportion of LR IV fluids following implementation |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Rate of hospital admission and readmission | Within 30 days of initial ED encounter | — |
| Cost | Through study completion (an average of 1 year) | Direct costs of ED care and hospitalization |
Countries
United States
Outcome results
None listed